Skip to the main content.
Request a Quote

Cell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services Portfolio. Read the Press Release

At Fluxion, we’re passionate about delivering cell-based solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Nicotinic Acetylcholine Receptors


Nicotinic acetylcholine receptors (nAChRs) are a class of pentameric ligand-gated ion channels involved in a wide variety of complex brain functions (memory, cognition, etc.) and neuromuscular transmission and play a role in pathological conditions such as Alzheimer’s and Parkinson’s disease, schizophrenia and nicotine addiction. Additionally, nicotinic receptor agonists have potential as analgesics, anxiolytics and cognitive enhancers. The search for modulators of nAChR channels has been hampered by the lack of suitable high throughput electrophysiology platforms with the ability to interrogate fast desensitizing ligand gated channels.

IonFlux Mercury was designed from the start with the needs of fast desensitizing nicotinic receptor assays in mind. The system’s precise fluidic control, fast liquid exchange, and continuous flow allow for repetitive serial application of acetylcholine or other ligands. Features include:

  • Rapid additions of ligand delivers fast current activation

  • Continuous flow produces rapid and complete ligand removal

  • Wash steps between ligand application eliminates need for addition of enzymes or other additive drugs.


Cell nAChR Receptor




Stable serial current activation of various nAChR cell ines


Controlled recovery from desensitization of alpha1 nAChR